237 related articles for article (PubMed ID: 27391331)
21. Transgenic mice expressing hepatitis B virus X protein are more susceptible to carcinogen induced hepatocarcinogenesis.
Zhu H; Wang Y; Chen J; Cheng G; Xue J
Exp Mol Pathol; 2004 Feb; 76(1):44-50. PubMed ID: 14738868
[TBL] [Abstract][Full Text] [Related]
22. Absence of hepatic stellate cell retinoid lipid droplets does not enhance hepatic fibrosis but decreases hepatic carcinogenesis.
Kluwe J; Wongsiriroj N; Troeger JS; Gwak GY; Dapito DH; Pradere JP; Jiang H; Siddiqi M; Piantedosi R; O'Byrne SM; Blaner WS; Schwabe RF
Gut; 2011 Sep; 60(9):1260-8. PubMed ID: 21278145
[TBL] [Abstract][Full Text] [Related]
23. Growth arrest and DNA damage-inducible protein (GADD34) enhanced liver inflammation and tumorigenesis in a diethylnitrosamine (DEN)-treated murine model.
Chen N; Nishio N; Ito S; Tanaka Y; Sun Y; Isobe K
Cancer Immunol Immunother; 2015 Jun; 64(6):777-89. PubMed ID: 25832002
[TBL] [Abstract][Full Text] [Related]
24. 1,25-(OH)₂-vitamin D₃ prevents activation of hepatic stellate cells in vitro and ameliorates inflammatory liver damage but not fibrosis in the Abcb4(-/-) model.
Reiter FP; Hohenester S; Nagel JM; Wimmer R; Artmann R; Wottke L; Makeschin MC; Mayr D; Rust C; Trauner M; Denk GU
Biochem Biophys Res Commun; 2015 Apr; 459(2):227-233. PubMed ID: 25712522
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.
Wang J; Zhao J; Chu ES; Mok MT; Go MY; Man K; Heuchel R; Lan HY; Chang Z; Sung JJ; Yu J
J Pathol; 2013 Aug; 230(4):441-52. PubMed ID: 23625826
[TBL] [Abstract][Full Text] [Related]
26. The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma.
Uehara T; Pogribny IP; Rusyn I
Curr Protoc Pharmacol; 2014 Sep; 66():14.30.1-14.30.10. PubMed ID: 25181010
[TBL] [Abstract][Full Text] [Related]
27. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
[TBL] [Abstract][Full Text] [Related]
28. Chronic administration of diethylnitrosamine to induce hepatocarcinogenesis and to evaluate its synergistic effect with other hepatotoxins in mice.
Fuentes-Hernández S; Alarcón-Sánchez BR; Guerrero-Escalera D; Montes-Aparicio AV; Castro-Gil MP; Idelfonso-García OG; Rosas-Madrigal S; Aparicio-Bautista DI; Pérez-Hernández JL; Reyes-Gordillo K; Lakshman MR; Vásquez-Garzón VR; Baltiérrez-Hoyos R; López-González ML; Sierra-Santoyo A; Villa-Treviño S; Pérez-Carreón JI; Arellanes-Robledo J
Toxicol Appl Pharmacol; 2019 Sep; 378():114611. PubMed ID: 31176654
[TBL] [Abstract][Full Text] [Related]
29. Fibrosis-associated hepatocarcinogenesis revisited: Establishing standard medium-term chemically-induced male and female models.
Romualdo GR; Prata GB; da Silva TC; Fernandes AAH; Moreno FS; Cogliati B; Barbisan LF
PLoS One; 2018; 13(9):e0203879. PubMed ID: 30212575
[TBL] [Abstract][Full Text] [Related]
30. Histology, bioenergetics and oxidative stress in mouse liver exposed to N-diethylnitrosamine.
Santos NP; Pereira IC; Pires MJ; Lopes C; Andrade R; Oliveira MM; Colaço A; Peixoto F; Oliveira PA
In Vivo; 2012; 26(6):921-9. PubMed ID: 23160673
[TBL] [Abstract][Full Text] [Related]
31. Chemoprevention by lipid-soluble tea polyphenols in diethylnitrosamine/phenobarbital-induced hepatic pre-cancerous lesions.
Shen T; Khor SC; Zhou F; Duan T; Xu YY; Zheng YF; Hsu S; DE Stefano J; Yang J; Xu LH; Zhu XQ
Anticancer Res; 2014 Feb; 34(2):683-93. PubMed ID: 24511000
[TBL] [Abstract][Full Text] [Related]
32. Heterozygous p53-deficient (+/-) mice develop fewer p53-negative preneoplastic focal liver lesions in response to treatment with diethylnitrosamine than do wild-type (+/+) mice.
Finnberg N; Stenius U; Högberg J
Cancer Lett; 2004 Apr; 207(2):149-55. PubMed ID: 15072823
[TBL] [Abstract][Full Text] [Related]
33. Morphology and morphometric investigation of hepatocellular preneoplastic lesions and neoplasms in connexin32-deficient mice.
Evert M; Ott T; Temme A; Willecke K; Dombrowski F
Carcinogenesis; 2002 May; 23(5):697-703. PubMed ID: 12016140
[TBL] [Abstract][Full Text] [Related]
34. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
[TBL] [Abstract][Full Text] [Related]
35. Nelumbo nucifera leaf extract treatment attenuated preneoplastic lesions and oxidative stress in the livers of diethylnitrosamine-treated rats.
Horng CT; Huang CW; Yang MY; Chen TH; Chang YC; Wang CJ
Environ Toxicol; 2017 Nov; 32(11):2327-2340. PubMed ID: 28804948
[TBL] [Abstract][Full Text] [Related]
36. G protein-coupled estrogen receptor deficiency accelerates liver tumorigenesis by enhancing inflammation and fibrosis.
Wei T; Chen W; Wen L; Zhang J; Zhang Q; Yang J; Liu H; Chen BW; Zhou Y; Feng X; Yang Q; Bai X; Liang T
Cancer Lett; 2016 Nov; 382(2):195-202. PubMed ID: 27594673
[TBL] [Abstract][Full Text] [Related]
37. Production of liver preneoplasia and gallbladder agenesis in turkey fetuses administered diethylnitrosamine.
Williams GM; Brunnemann KD; Iatropoulos MJ; Smart DJ; Enzmann HG
Arch Toxicol; 2011 Jun; 85(6):681-7. PubMed ID: 20981410
[TBL] [Abstract][Full Text] [Related]
38. Cell expression patterns of CD147 in N-diethylnitrosamine/phenobarbital-induced mouse hepatocellular carcinoma.
Lu M; Wu J; He F; Wang XL; Li C; Chen ZN; Bian H
J Mol Histol; 2015 Feb; 46(1):79-91. PubMed ID: 25447507
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks.
Helms TH; Mullins RD; Thomas-Ahner JM; Kulp SK; Campbell MJ; Lucas F; Schmidt N; LeMoine DM; Getaneh S; Xie Z; Phelps MA; Clinton SK; Coss CC
Sci Rep; 2021 Feb; 11(1):3646. PubMed ID: 33574348
[TBL] [Abstract][Full Text] [Related]
40. Attenuation of steatohepatitis, fibrosis, and carcinogenesis in mice fed a methionine-choline deficient diet by CCAAT/enhancer-binding protein homologous protein deficiency.
Toriguchi K; Hatano E; Tanabe K; Takemoto K; Nakamura K; Koyama Y; Seo S; Taura K; Uemoto S
J Gastroenterol Hepatol; 2014 May; 29(5):1109-18. PubMed ID: 24329600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
